Stay updated on Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the usual study details, with a simple 403 page layout including header/footer, effectively preventing viewing of the NCT03264547 record.
    Difference
    20%
    Check dated 2026-09-20T02:10:31.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The revision tag on the study record was updated from v3.6.5 to v3.6.6. This update reflects a newer version of the entry without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-30T00:31:32.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.4 to v3.6.5, reflecting a new iteration of the page metadata. This change does not modify the study content or visible details.
    Difference
    0.1%
    Check dated 2026-08-08T20:47:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This reflects a small update to the page version rather than changes to substantive study information.
    Difference
    0.1%
    Check dated 2026-07-25T13:05:45.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section, detailing updated subgroup analyses of JBCRG-M06/EMERALD for HER2-positive locally advanced or metastatic breast cancer and listing authors such as Masuda et al. The citation is for Breast Cancer Research and Treatment (2026) with DOI 10.1007/s10549-026-08004-5.
    Difference
    0.1%
    Check dated 2026-07-11T05:57:22.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small update to the page’s metadata. No substantive content changes are introduced.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:57.000Z thumbnail image

Stay in the know with updates to Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin Combo vs. Taxane Combo in HER2+ Breast Cancer Clinical Trial page.